AstraZeneca acquires EsoBiotec in $1 bn deal

AstraZeneca acquires EsoBiotec in $1 bn deal

18 Mar 2025

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of biotechnology company EsoBiotech in a $1 billion transaction

AstraZeneca starts global recall of its controversial Covid 19 vaccine

AstraZeneca starts global recall of its controversial Covid 19 vaccine

08 May 2024

Days after admitting that its Covid 19 vaccine could cause blood clot in some people, British-Swedish pharmaceutical company AstraZeneca

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

27 Dec 2023

Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.

AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn

11 Jan 2023

AstraZeneca to acquire biotech firm TeneoTwo in a deal worth more than $1.27 billion

08 Jul 2022

AstraZeneca to acquire Alexion in a $39 bn cash-and-stock deal

23 Dec 2020

India may grant emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine: report

24 Nov 2020

AstraZeneca Covid-19 vaccine trial volunteer in Brazil dies; testing to continue

26 Oct 2020

Sun Pharma licenses AstraZeneca to sell its oncology drugs in China

06 Nov 2019

AstraZeneca and Merck claim Japanese approval for anti-cancer drug Lynparza

20 Jun 2019

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!

Latest articles on AstraZeneca from Informachine

Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for Breztri in patients with uncontrolled asthma published in The Lancet Respiratory Medicine

13 Feb 2026

Full Year and Q4 2025 results

10 Feb 2026

Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy

03 Feb 2026

Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus

03 Feb 2026

Imfinzi perioperative regimen recommended for approval in the EU by CHMP for patients with early gastric and gastroesophageal cancers

02 Feb 2026

AstraZeneca begins trading on the New York Stock Exchange

02 Feb 2026

AstraZeneca enhances its weight management portfolio through collaboration agreement with CSPC Pharmaceuticals

30 Jan 2026

AstraZeneca plans to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines

29 Jan 2026

AstraZeneca to complete direct listing of ordinary shares and all US debt securities on the New York Stock Exchange

20 Jan 2026

AstraZeneca appoints Joris Silon as Head of Investor Relations

12 Jan 2026

View details about the software product Informachine News Trackers